News & Articles
Selected Filters:
QIAGEN receives FDA authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen
QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, provides accurate and objective results in 2 to 15 minutes
How targeting B cells could lead to improved immunotherapies for lung cancer
Dr. Tullia Bruno shares her multi-omics approach to investigating the role of B cells and tertiary lymphoid structures in the quest for novel cancer therapies
Supporting Indian biotherapeutic companies with antibody development
The partnership between Fusion Antibodies and BioTickle delivers value with proprietary antibody discovery, engineering and cell line technologies
Longer interval between Pfizer vaccine doses boosts immunity
Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells
Discover the Latest in Stem Cell Research
New application notes, videos and products
How to accelerate drug discovery with optimized high-throughput screening
Antibody expert, Dr. Chelcie Eller, shares how to achieve reliable and reproducible high-throughput drug and biomarker screening
Confidence in your knock-outs: The importance of robustly validated cell lines
Quality control and antibody validation expert Julie Wickenden shares how she works to ensure full protein knock-out in Abcam’s cell line portfolio
Discovery and development of antibody therapies for COVID-19
Watch this on-demand webinar to discover how neutralizing antibodies can be used as a drug modality for the treatment of COVID-19
Population-wide immune responses to SARS-CoV-2: Insights from quantifying the antibody response
Watch this on-demand webinar to discover a new approach to profiling antibody responses by quantifying affinity and concentration
LegoChem and Iksuda expand license agreement for development of antibody-drug conjugates
The expanded agreement grants Iksuda access to LegoChem Biosciences’ next generation ADC platform for up to six targets
Why serology tests are shaping the future of vaccine development
Learn more about the efficient and reproducible multiplex immunoassays set to change the way COVID-19 researchers profile antibody response
Protein identified as new therapeutic anti-viral target for COVID-19
The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality
SARS-CoV-2 variants: Are Ct values an unused piece of the profiling puzzle?
Infectious disease scientist Dr. Padmapriya Banada explores the potential of cycle threshold values and reveals her melt-based assay alternative
Your next tissue diagnostics educational journey awaits! Introducing the immunohistochemistry free summer webinar series, from Merck
This multi-session event will take you on a weekly path of discovery, featuring the latest in IHC antibodies, histology troubleshooting techniques, case studies in pathology, and more
Roche obtains CE mark for the SARS-CoV-2 Antigen Self-Test Nasal allowing for rapid self-testing of COVID-19 at home
The test will be widely available to individuals through pharmacies and other locations in accordance with local guidelines and testing strategies